US FDA Grants Approval For Zanidatamab Ziihera Bispecific Antibody For Biliary Tract Cancer
November 25, 2024 05:47 ET
|
KuicK Research
Delhi, Nov. 25, 2024 (GLOBE NEWSWIRE) -- In November 2024, Jazz Pharmaceuticals announced that the US FDA granted accelerated approval for zanidatamab, a bispecific antibody, for the treatment of...